Pmv Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$1.38(as of Apr 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Pmv Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.38
Ticker SymbolPMVP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees54
CountyUSA
Market Cap$73.6M

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Pmv Pharmaceuticals Inc In Our Stock Scanner

As of Apr 20, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.